Literature DB >> 31059612

Cognitive impairment as a diagnostic criterion and treatment target in schizophrenia.

Michael Davidson1.   

Abstract

Entities:  

Year:  2019        PMID： 31059612      PMCID： PMC6502436          DOI： 10.1002/wps.20651

Source DB:  PubMed          Journal:  World Psychiatry        ISSN： 1723-8617            Impact factor:   49.548


× No keyword cloud information.
  7 in total

Review 1.  α7 Nicotinic Acetylcholine Receptor: A Potential Target in Treating Cognitive Decline in Schizophrenia.

Authors:  Candace Jones
Journal:  J Clin Psychopharmacol       Date:  2018-06       Impact factor: 3.153

2.  Cognitive performance of male adolescents is lower than controls across psychiatric disorders: a population-based study.

Authors:  M Weiser; A Reichenberg; J Rabinowitz; H Y Knobler; G Lubin; R Yazvitzky; D Nahon; R C Gur; M Davidson
Journal:  Acta Psychiatr Scand       Date:  2004-12       Impact factor: 6.392

3.  Nonsocial and social cognition in schizophrenia: current evidence and future directions.

Authors:  Michael F Green; William P Horan; Junghee Lee
Journal:  World Psychiatry       Date:  2019-06       Impact factor: 49.548

Review 4.  An Integrative Perspective on the Role of Dopamine in Schizophrenia.

Authors:  Tiago V Maia; Michael J Frank
Journal:  Biol Psychiatry       Date:  2016-06-01       Impact factor: 13.382

Review 5.  Has an angel shown the way? Etiological and therapeutic implications of the PCP/NMDA model of schizophrenia.

Authors:  Daniel C Javitt; Stephen R Zukin; Uriel Heresco-Levy; Daniel Umbricht
Journal:  Schizophr Bull       Date:  2012-09       Impact factor: 9.306

6.  Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST).

Authors:  Michael Davidson; Silvana Galderisi; Mark Weiser; Nomi Werbeloff; Wolfgang W Fleischhacker; Richard S Keefe; Han Boter; Ireneus P M Keet; Dan Prelipceanu; Janusz K Rybakowski; Jan Libiger; Martina Hummer; Sonia Dollfus; Juan J López-Ibor; Luchezar G Hranov; Wolfgang Gaebel; Joseph Peuskens; Nils Lindefors; Anita Riecher-Rössler; René S Kahn
Journal:  Am J Psychiatry       Date:  2009-04-15       Impact factor: 18.112

7.  A multicenter, add-on randomized controlled trial of low-dose d-serine for negative and cognitive symptoms of schizophrenia.

Authors:  Mark Weiser; Uriel Heresco-Levy; Michael Davidson; Daniel C Javitt; Nomi Werbeloff; Ari A Gershon; Yehuda Abramovich; Daniela Amital; Adiel Doron; Shai Konas; Yehiel Levkovitz; David Liba; Alexander Teitelbaum; Mordechai Mashiach; Yosef Zimmerman
Journal:  J Clin Psychiatry       Date:  2012-06       Impact factor: 4.384
  7 in total
  11 in total

1.  One-day tropisetron treatment improves cognitive deficits and P50 inhibition deficits in schizophrenia.

Authors:  Luyao Xia; Lei Liu; Xiaohong Hong; Dongmei Wang; Gaoxia Wei; Jiesi Wang; Huixia Zhou; Hang Xu; Yang Tian; Qilong Dai; Hanjing E Wu; Catherine Chang; Li Wang; Thomas R Kosten; Xiang Yang Zhang
Journal:  Neuropsychopharmacology       Date:  2020-04-29       Impact factor: 7.853

Review 2.  Gender Differences in Clinical and Psychosocial Features Among Persons With Schizophrenia: A Mini Review.

Authors:  Giulia Maria Giordano; Paola Bucci; Armida Mucci; Pasquale Pezzella; Silvana Galderisi
Journal:  Front Psychiatry       Date:  2021-12-22       Impact factor: 4.157

Review 3.  Improving Knowledge on Pathways to Functional Outcome in Schizophrenia: Main Results From the Italian Network for Research on Psychoses.

Authors:  Luigi Giuliani; Giulia Maria Giordano; Paola Bucci; Pasquale Pezzella; Francesco Brando; Silvana Galderisi
Journal:  Front Psychiatry       Date:  2021-12-14       Impact factor: 4.157

4.  Investigating the Relationship between White Matter Connectivity and Motivational Circuits in Subjects with Deficit Schizophrenia: A Diffusion Tensor Imaging (DTI) Study.

Authors:  Giulia M Giordano; Pasquale Pezzella; Mario Quarantelli; Paola Bucci; Anna Prinster; Andrea Soricelli; Andrea Perrottelli; Luigi Giuliani; Michele Fabrazzo; Silvana Galderisi
Journal:  J Clin Med       Date:  2021-12-23       Impact factor: 4.241

5.  Tracing Links Between Early Auditory Information Processing and Negative Symptoms in Schizophrenia: An ERP Study.

Authors:  Giulia M Giordano; Francesco Brando; Andrea Perrottelli; Giorgio Di Lorenzo; Alberto Siracusano; Luigi Giuliani; Pasquale Pezzella; Mario Altamura; Antonello Bellomo; Giammarco Cascino; Antonio Del Casale; Palmiero Monteleone; Maurizio Pompili; Silvana Galderisi; Mario Maj
Journal:  Front Psychiatry       Date:  2021-12-20       Impact factor: 4.157

6.  Three-way parallel group independent component analysis: Fusion of spatial and spatiotemporal magnetic resonance imaging data.

Authors:  Shile Qi; Rogers F Silva; Daoqiang Zhang; Sergey M Plis; Robyn Miller; Victor M Vergara; Rongtao Jiang; Dongmei Zhi; Jing Sui; Vince D Calhoun
Journal:  Hum Brain Mapp       Date:  2021-11-22       Impact factor: 5.038

7.  We Should Improve Personalization of Management in Patients with a Diagnosis of Schizophrenia.

Authors:  Alfonso Tortorella
Journal:  J Clin Med       Date:  2021-12-30       Impact factor: 4.241

Review 8.  Do DSM classifications help or hinder
drug development?
.

Authors:  Michael Davidson; Cristian Gabos-Grecu
Journal:  Dialogues Clin Neurosci       Date:  2020-03       Impact factor: 5.986

9.  Mismatch Negativity and P3a Impairment through Different Phases of Schizophrenia and Their Association with Real-Life Functioning.

Authors:  Giulia M Giordano; Luigi Giuliani; Andrea Perrottelli; Paola Bucci; Giorgio Di Lorenzo; Alberto Siracusano; Francesco Brando; Pasquale Pezzella; Michele Fabrazzo; Mario Altamura; Antonello Bellomo; Giammarco Cascino; Anna Comparelli; Palmiero Monteleone; Maurizio Pompili; Silvana Galderisi; Mario Maj
Journal:  J Clin Med       Date:  2021-12-13       Impact factor: 4.241

10.  Investigating the Relationships of P3b with Negative Symptoms and Neurocognition in Subjects with Chronic Schizophrenia.

Authors:  Giulia M Giordano; Andrea Perrottelli; Armida Mucci; Giorgio Di Lorenzo; Mario Altamura; Antonello Bellomo; Roberto Brugnoli; Giulio Corrivetti; Paolo Girardi; Palmiero Monteleone; Cinzia Niolu; Silvana Galderisi; Mario Maj
Journal:  Brain Sci       Date:  2021-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.